HEADER IMMUNE SYSTEM 11-JUL-01 1JK8 TITLE CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: MHC CLASS II HLA-DQ8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA CHAIN (DQA1*0301); COMPND 5 SYNONYM: MHC CLASS II ANTIGEN,MHC CLASS II PROTEIN,MAJOR COMPND 6 HISTOCOMPATIBILITY COMPLEX,CLASS II,DQ ALPHA 1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: MHC CLASS II HLA-DQ8; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: BETA CHAIN (DQB1*0302); COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: INSULIN B PEPTIDE; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: PEPTIDE (9-SHLVEALYLVCGERG-23); COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-DQA1, DQA1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: HLA-DQB1; SOURCE 15 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 16 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606; SOURCE 24 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 25 OF THIS PEPTIDE OCCURS NATURALLY IN HUMANS (HOMO SAPIENS). KEYWDS HLA-DQ8, INSULIN B PEPTIDE, TYPE 1 DIABETES, AUTOIMMUNITY, IMMUNE KEYWDS 2 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR K.H.LEE,K.W.WUCHERPFENNIG,D.C.WILEY REVDAT 7 16-OCT-24 1JK8 1 REMARK REVDAT 6 18-SEP-24 1JK8 1 COMPND SOURCE REMARK DBREF REVDAT 6 2 1 SEQADV SEQRES HETSYN HELIX REVDAT 6 3 1 SHEET ATOM REVDAT 5 29-JUL-20 1JK8 1 REVDAT 4 31-JAN-18 1JK8 1 REVDAT 3 13-JUL-11 1JK8 1 REVDAT 2 24-FEB-09 1JK8 1 REVDAT 1 22-AUG-01 1JK8 0 JRNL AUTH K.H.LEE,K.W.WUCHERPFENNIG,D.C.WILEY JRNL TITL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX AND JRNL TITL 2 SUSCEPTIBILITY TO TYPE 1 DIABETES. JRNL REF NAT.IMMUNOL. V. 2 501 2001 JRNL REFN ISSN 1529-2908 JRNL PMID 11376336 JRNL DOI 10.1038/88694 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1016975.090 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 17854 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1765 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2396 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 257 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3114 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.47000 REMARK 3 B22 (A**2) : 4.63000 REMARK 3 B33 (A**2) : -5.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.06000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.39 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.800 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.370 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.840 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.320 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.530 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 24.65 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JK8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-01. REMARK 100 THE DEPOSITION ID IS D_1000013871. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18183 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, MAGNESIUM ACETATE, PH 3.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 18K, TEMPERATURE REMARK 280 291.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.43100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 105 CG CD NE CZ NH1 NH2 REMARK 470 THR B 106 OG1 CG2 REMARK 470 GLU B 107 CG CD OE1 OE2 REMARK 470 LEU B 109 CG CD1 CD2 REMARK 470 ASN B 110 CG OD1 ND2 REMARK 470 HIS B 111 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 112 CG ND1 CD2 CE1 NE2 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ARG B 105 REMARK 475 THR B 106 REMARK 475 GLU B 107 REMARK 475 ALA B 108 REMARK 475 LEU B 109 REMARK 475 ASN B 110 REMARK 475 HIS B 111 REMARK 475 HIS B 112 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 37 CG GLU A 37 CD -0.342 REMARK 500 GLU A 88 CG GLU A 88 CD 0.252 REMARK 500 GLN A 101 CG GLN A 101 CD -0.140 REMARK 500 ASP A 171 CG ASP A 171 OD1 0.455 REMARK 500 PRO A 180 C GLU A 181 N -0.217 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 88 CB - CG - CD ANGL. DEV. = -20.3 DEGREES REMARK 500 ASP A 171 OD1 - CG - OD2 ANGL. DEV. = -29.0 DEGREES REMARK 500 ASP A 171 CB - CG - OD1 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP A 171 CB - CG - OD2 ANGL. DEV. = 24.7 DEGREES REMARK 500 PRO A 180 O - C - N ANGL. DEV. = -10.2 DEGREES REMARK 500 SER B 104 O - C - N ANGL. DEV. = -18.5 DEGREES REMARK 500 ARG B 105 C - N - CA ANGL. DEV. = 16.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 113 128.46 -178.08 REMARK 500 HIS A 143 9.17 80.21 REMARK 500 PRO A 180 78.10 -51.64 REMARK 500 ASN B 19 73.21 59.65 REMARK 500 ASN B 33 -99.58 68.23 REMARK 500 PRO B 52 2.26 -67.32 REMARK 500 CYS B 79 -70.56 -53.73 REMARK 500 THR B 89 -94.97 -128.77 REMARK 500 ARG B 105 -83.86 104.67 REMARK 500 THR B 106 -146.27 -162.80 REMARK 500 ALA B 108 116.62 64.98 REMARK 500 ASN B 110 55.51 101.03 REMARK 500 HIS B 111 4.90 58.29 REMARK 500 ASN B 113 167.24 -33.90 REMARK 500 TYR B 123 138.27 -170.07 REMARK 500 PRO B 124 -175.03 -67.34 REMARK 500 ASN B 134 -112.75 62.06 REMARK 500 GLN B 191 72.66 70.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ASP A 171 0.11 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER B 104 17.44 REMARK 500 REMARK 500 REMARK: NULL DBREF 1JK8 A 2 181 UNP Q5Y7H0 Q5Y7H0_HUMAN 27 207 DBREF 1JK8 B 3 192 UNP O19714 O19714_HUMAN 24 213 DBREF 1JK8 C 1 14 PDB 1JK8 1JK8 1 14 SEQADV 1JK8 ALA A 157 UNP Q5Y7H0 ASP 183 ENGINEERED MUTATION SEQRES 1 A 181 VAL ALA ASP HIS VAL ALA SER TYR GLY VAL ASN LEU TYR SEQRES 2 A 181 GLN SER TYR GLY PRO SER GLY GLN TYR SER HIS GLU PHE SEQRES 3 A 181 ASP GLY ASP GLU GLU PHE TYR VAL ASP LEU GLU ARG LYS SEQRES 4 A 181 GLU THR VAL TRP GLN LEU PRO LEU PHE ARG ARG PHE ARG SEQRES 5 A 181 ARG PHE ASP PRO GLN PHE ALA LEU THR ASN ILE ALA VAL SEQRES 6 A 181 LEU LYS HIS ASN LEU ASN ILE VAL ILE LYS ARG SER ASN SEQRES 7 A 181 SER THR ALA ALA THR ASN GLU VAL PRO GLU VAL THR VAL SEQRES 8 A 181 PHE SER LYS SER PRO VAL THR LEU GLY GLN PRO ASN THR SEQRES 9 A 181 LEU ILE CYS LEU VAL ASP ASN ILE PHE PRO PRO VAL VAL SEQRES 10 A 181 ASN ILE THR TRP LEU SER ASN GLY HIS SER VAL THR GLU SEQRES 11 A 181 GLY VAL SER GLU THR SER PHE LEU SER LYS SER ASP HIS SEQRES 12 A 181 SER PHE PHE LYS ILE SER TYR LEU THR PHE LEU PRO SER SEQRES 13 A 181 ALA ASP GLU ILE TYR ASP CYS LYS VAL GLU HIS TRP GLY SEQRES 14 A 181 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PRO GLU SEQRES 1 B 190 SER PRO GLU ASP PHE VAL TYR GLN PHE LYS GLY MET CYS SEQRES 2 B 190 TYR PHE THR ASN GLY THR GLU ARG VAL ARG LEU VAL THR SEQRES 3 B 190 ARG TYR ILE TYR ASN ARG GLU GLU TYR ALA ARG PHE ASP SEQRES 4 B 190 SER ASP VAL GLY VAL TYR ARG ALA VAL THR PRO LEU GLY SEQRES 5 B 190 PRO PRO ALA ALA GLU TYR TRP ASN SER GLN LYS GLU VAL SEQRES 6 B 190 LEU GLU ARG THR ARG ALA GLU LEU ASP THR VAL CYS ARG SEQRES 7 B 190 HIS ASN TYR GLN LEU GLU LEU ARG THR THR LEU GLN ARG SEQRES 8 B 190 ARG VAL GLU PRO THR VAL THR ILE SER PRO SER ARG THR SEQRES 9 B 190 GLU ALA LEU ASN HIS HIS ASN LEU LEU VAL CYS SER VAL SEQRES 10 B 190 THR ASP PHE TYR PRO ALA GLN ILE LYS VAL ARG TRP PHE SEQRES 11 B 190 ARG ASN ASP GLN GLU GLU THR THR GLY VAL VAL SER THR SEQRES 12 B 190 PRO LEU ILE ARG ASN GLY ASP TRP THR PHE GLN ILE LEU SEQRES 13 B 190 VAL MET LEU GLU MET THR PRO GLN ARG GLY ASP VAL TYR SEQRES 14 B 190 THR CYS HIS VAL GLU HIS PRO SER LEU GLN ASN PRO ILE SEQRES 15 B 190 ILE VAL GLU TRP ARG ALA GLN SER SEQRES 1 C 14 LEU VAL GLU ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY SEQRES 2 C 14 GLY MODRES 1JK8 ASN A 78 ASN GLYCOSYLATION SITE HET NAG A 401 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 FORMUL 5 HOH *70(H2 O) HELIX 1 AA1 LEU A 45 ARG A 52 1 8 HELIX 2 AA2 ASP A 55 SER A 77 1 23 HELIX 3 AA3 GLY B 54 SER B 63 1 10 HELIX 4 AA4 GLN B 64 VAL B 78 1 15 HELIX 5 AA5 VAL B 78 ARG B 88 1 11 HELIX 6 AA6 THR B 89 ARG B 93 5 5 SHEET 1 AA1 8 GLU A 40 TRP A 43 0 SHEET 2 AA1 8 ASP A 29 ASP A 35 -1 N TYR A 33 O VAL A 42 SHEET 3 AA1 8 SER A 19 PHE A 26 -1 N HIS A 24 O GLU A 31 SHEET 4 AA1 8 HIS A 5 GLN A 14 -1 N GLN A 14 O SER A 19 SHEET 5 AA1 8 VAL B 8 THR B 18 -1 O PHE B 11 N ASN A 11 SHEET 6 AA1 8 ARG B 23 TYR B 32 -1 O ILE B 31 N GLN B 10 SHEET 7 AA1 8 GLU B 35 ASP B 41 -1 O ALA B 38 N TYR B 30 SHEET 8 AA1 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA2 4 GLU A 88 SER A 93 0 SHEET 2 AA2 4 ASN A 103 ILE A 112 -1 O ASP A 110 N GLU A 88 SHEET 3 AA2 4 PHE A 145 PHE A 153 -1 O PHE A 145 N ILE A 112 SHEET 4 AA2 4 VAL A 132 GLU A 134 -1 N SER A 133 O TYR A 150 SHEET 1 AA3 4 GLU A 88 SER A 93 0 SHEET 2 AA3 4 ASN A 103 ILE A 112 -1 O ASP A 110 N GLU A 88 SHEET 3 AA3 4 PHE A 145 PHE A 153 -1 O PHE A 145 N ILE A 112 SHEET 4 AA3 4 LEU A 138 SER A 139 -1 N LEU A 138 O PHE A 146 SHEET 1 AA4 4 HIS A 126 VAL A 128 0 SHEET 2 AA4 4 ASN A 118 SER A 123 -1 N SER A 123 O HIS A 126 SHEET 3 AA4 4 TYR A 161 GLU A 166 -1 O LYS A 164 N THR A 120 SHEET 4 AA4 4 LEU A 174 TRP A 178 -1 O TRP A 178 N TYR A 161 SHEET 1 AA5 4 THR B 98 PRO B 103 0 SHEET 2 AA5 4 LEU B 114 PHE B 122 -1 O SER B 118 N THR B 100 SHEET 3 AA5 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 AA5 4 VAL B 142 SER B 144 -1 N VAL B 143 O MET B 160 SHEET 1 AA6 4 THR B 98 PRO B 103 0 SHEET 2 AA6 4 LEU B 114 PHE B 122 -1 O SER B 118 N THR B 100 SHEET 3 AA6 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 AA6 4 ILE B 148 ARG B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 AA7 4 GLN B 136 GLU B 138 0 SHEET 2 AA7 4 LYS B 128 ARG B 133 -1 N TRP B 131 O GLU B 138 SHEET 3 AA7 4 VAL B 170 GLU B 176 -1 O GLU B 176 N LYS B 128 SHEET 4 AA7 4 ILE B 184 ARG B 189 -1 O TRP B 188 N TYR B 171 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.03 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.03 LINK ND2 ASN A 78 C1 NAG A 401 1555 1555 1.45 CISPEP 1 GLY A 17 PRO A 18 0 -0.35 CISPEP 2 PHE A 113 PRO A 114 0 -0.03 CISPEP 3 TYR B 123 PRO B 124 0 -0.50 CRYST1 66.034 42.862 87.467 90.00 102.48 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015144 0.000000 0.003352 0.00000 SCALE2 0.000000 0.023331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011710 0.00000